Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARDELYX, INC. | Director | Common Stock | 1.43M | $6.58M | $4.62 | Nov 13, 2024 | Direct |
IMARA Inc. | Director | Common Stock | 229K | $3.47M | $15.14 | Jun 2, 2022 | Direct |
Mersana Therapeutics, Inc. | Director | Common Stock | 589K | $1.6M | $2.71 | Jan 2, 2024 | Direct |
NOVAVAX INC | Director | Common Stock | 50.5K | $702K | $13.90 | Jun 12, 2024 | Direct |
NOVAVAX INC | Director | Stock Option (Right to Buy) | 15.6K | $248K | $15.86 | Jun 12, 2024 | Direct |
NOVAVAX INC | Director | Restricted Stock Units | 10.4K | $145K | $13.90 | Jun 12, 2024 | Direct |
ARDELYX, INC. | Director | Stock Option (Right to Buy) | 40.2K | $93.4K | $2.32 | Jun 14, 2024 | Direct |
Mersana Therapeutics, Inc. | Director | Common Stock | 9.6K | $26K | $2.71 | Jan 2, 2024 | Indirect |
Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 1.58M | Jul 1, 2024 | Direct | ||
Mersana Therapeutics, Inc. | Director | Stock Option (right to buy) | 55K | Jun 11, 2024 | Direct | ||
IMARA Inc. | Director | Stock Options (Right to Buy) | 8.5K | Jun 2, 2022 | Direct | ||
Epizyme, Inc. | Director | Common Stock, par value $0.0001 | 0 | $1.41 | Aug 12, 2022 | Direct | |
Epizyme, Inc. | Director | Common Stock, par value $0.0001 | 0 | $1.41 | Aug 12, 2022 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARDX | ARDELYX, INC. | Nov 13, 2024 | 1 | $997K | 4 | Nov 14, 2024 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
ARDX | ARDELYX, INC. | Jun 14, 2024 | 2 | $0 | 4 | Jun 17, 2024 | Director |
NVAX | NOVAVAX INC | Jun 12, 2024 | 4 | $248K | 4 | Jun 14, 2024 | Director |
MRSN | Mersana Therapeutics, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
MRSN | Mersana Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
MRSN | Mersana Therapeutics, Inc. | Oct 2, 2023 | 1 | $0 | 4 | Oct 4, 2023 | Director |
MRSN | Mersana Therapeutics, Inc. | Jul 3, 2023 | 1 | $0 | 4 | Jul 6, 2023 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 3, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
ARDX | ARDELYX, INC. | Jun 15, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
NVAX | NOVAVAX INC | Jun 10, 2023 | 4 | $0 | 4 | Jun 13, 2023 | Director |
MRSN | Mersana Therapeutics, Inc. | Jun 8, 2023 | 2 | $0 | 4 | Jun 12, 2023 | Director |
MRSN | Mersana Therapeutics, Inc. | Apr 3, 2023 | 1 | $0 | 4 | Apr 5, 2023 | Director |
ARDX | ARDELYX, INC. | Nov 17, 2022 | 1 | $1M | 4 | Nov 17, 2022 | Director |
EPZM | Epizyme, Inc. | Aug 12, 2022 | 3 | $0 | 4 | Aug 16, 2022 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
EPZM | Epizyme, Inc. | Jun 30, 2022 | 1 | $23.7K | 4 | Jul 5, 2022 | Director |
NVAX | NOVAVAX INC | Jun 17, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
ARDX | ARDELYX, INC. | Jun 15, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
NVAX | NOVAVAX INC | Jun 10, 2022 | 2 | $0 | 4 | Jun 14, 2022 | Director |
MRSN | Mersana Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
ELVN | IMARA Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
EPZM | Epizyme, Inc. | May 17, 2022 | 2 | $0 | 4 | May 19, 2022 | Director |
EPZM | Epizyme, Inc. | Mar 31, 2022 | 1 | $23.8K | 4 | Apr 1, 2022 | Director |
ELVN | IMARA Inc. | Feb 18, 2022 | 3 | $220K | 4 | Feb 23, 2022 | Director |
ELVN | IMARA Inc. | Feb 15, 2022 | 3 | $54.7K | 4 | Feb 17, 2022 | Director |
ELVN | IMARA Inc. | Feb 10, 2022 | 3 | $39.2K | 4 | Feb 14, 2022 | Director |
MRSN | Mersana Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
EPZM | Epizyme, Inc. | Dec 31, 2021 | 1 | $23.8K | 4 | Jan 4, 2022 | Director |
EPZM | Epizyme, Inc. | Sep 30, 2021 | 1 | $23.8K | 4 | Oct 1, 2021 | Director |
NVAX | NOVAVAX INC | Sep 23, 2021 | 5 | -$6.31M | 4 | Sep 24, 2021 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
EPZM | Epizyme, Inc. | Jun 30, 2021 | 1 | $23.7K | 4 | Jul 1, 2021 | Director |
ELVN | IMARA Inc. | Jun 29, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |
NVAX | NOVAVAX INC | Jun 17, 2021 | 2 | $0 | 4 | Jun 22, 2021 | Director |
ARDX | ARDELYX, INC. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
MRSN | Mersana Therapeutics, Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |
EPZM | Epizyme, Inc. | Jun 11, 2021 | 2 | $0 | 4 | Jun 15, 2021 | Director |